Disorders of the gut-brain interaction (DGBI) are characterized by gastrointestinal symptoms resulting from a combination of various factors—including motility disorders, visceral hypersensitivity, and dysbiosis. For many years, research into and clinical management of GBI have been based on diagnostic criteria published by the Rome Foundation. The Rome V criteria, published in 2026, provide a comprehensive overview of the current evidence-based knowledge, with a focus on changes from the previous version (Rome IV).
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Disorders of the Gut-Brain Interaction
Rome V Criteria: What Has Changed, and What Has Remained the Same?
- Tourette Syndrome
What can be done to treat this tic disorder?
- Chronic Hepatitis B: Is a Cure in Sight?
Phase III Trial of Temporary Treatment with Bepirovirsen Was Successful
- Congenital Vascular Malformations
Personalized Treatment Before a Planned Pregnancy
- Fibromyalgia Syndrome
Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity
- Clinically Suspected Arthralgias
“Watchful waiting” or intervention?
- Tumors of the Calcaneus
Diagnostic Challenges of Rare Heel Tumors
- Upper GI Tract Bleeding: Hematemesis, Hematochezia, or Melena?